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ALERT 
Panic disorder, with or without agoraphobia, can increase the risk for 
suicidal ideation in behavioral health patients.14 
 
Assess a patient’s cardiac status when panic disorder symptoms are 
present; panic disorder may be associated with cardiac disorders.4 
 
OVERVIEW 
Panic disorder is an anxiety disorder that involves the sudden and recurrent 
experience of intense fear or intense discomfort, referred to as a panic attack. The 
patient having a panic attack can experience both physical and cognitive symptoms.1 
Due to the somatic nature of the symptoms, patients with panic disorder seek 
medical attention more often than the general public.6 According to the Diagnostic 
and Statistical Manual of Mental Disorders, 5th edition (DSM-5), a patient with panic 
disorder must experience at least four of these thirteen signs or symptoms, and 
these signs or symptoms must not be related to another condition:1  
• Palpitations, pounding heart, or accelerated heart rate 
• Sweating 
• Trembling or shaking 
• Sensations of shortness of breath or smothering 
• Feelings of choking 
• Chest pain or discomfort 
• Nausea or abdominal distress 
• Feeling dizzy, unsteady, light-headed, or faint 
• Chills or heat sensations 
• Paresthesia (numbness or tingling sensation) 
• Derealization (feelings of unreality) or depersonalization (being detached from 
oneself) 
• Fear of losing control or going crazy 
• Fear of dying 
 
Agoraphobia is a fear or anxiety about two or more of these five situations delineated 
in the DSM-5:1 
• Using public transportation (e.g., automobiles, buses, trains, ships, planes) 
• Being in open spaces (e.g., parking lots, marketplaces, bridges) 
• Being in enclosed spaces (e.g., shops, theaters, cinemas) 
• Standing in line or being in a crowd 
• Being outside of the home alone 
 
The fear is related to thoughts that escape will be difficult or help will not be 
available if panic symptoms or other embarrassing symptoms develop.1  
 
Although panic disorder and agoraphobia may begin in childhood, the typical age of 
onset for panic disorder is early adulthood and late adolescence and early adulthood 
for agoraphobia.1 Both disorders are more common in female patients.1  
There is evidence that both disorders have a genetic component.7 Several studies 
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Patients can experience panic disorder and agoraphobia independent of each other or 
they can experience both disorders.1 Patients with panic disorder and agoraphobia 
experience more severe symptoms and have a greater number of comorbid 
psychiatric conditions.11  
 
Signs and symptoms of panic disorder can appear as signs and symptoms of cardiac 
or respiratory disorders, and panic disorder can also increase the risk of comorbid 
cardiac and respiratory disorders.9 Therefore, it is essential that an evaluation of the 
patient’s medical condition be included in any assessment of a patient who presents 
with physical manifestations consistent with panic disorder.9 Patients can also 
experience panic attacks that do not involve any experience of fear or anxiety. These 
are referred to as nonfearful panic attacks.10 
 
It is also important to realize that not all panic attacks happen within the context of a 
panic disorder.2 Panic attacks can happen as isolated events or in the context of 
another disorder such as posttraumatic stress disorder (PTSD), social anxiety 




• Provide developmentally and culturally appropriate education based on the desire 
for knowledge, readiness to learn, and overall neurologic and psychosocial state.  
• Establish a rapport with the patient, family, and designated support person that 
encourages questions. Answer them as they arise.  
• Consider the patient’s, family’s, and designated support person’s values and 
goals in the decision-making process.  
• Assist the patient, family, and designated support person with recognizing signs 
and symptoms of acute exacerbation of the illness.  
• Explain the manifestations of the illness and expected progression of symptoms if 
the patient experiences a relapse. Describe what the family and designated 
support person are likely to see, hear, and experience (e.g., patient reports of 
pounding heartbeat, sweating, shortness of breath, chest pain, nausea, dizziness, 
tingling, feeling unreal or detached, fear of losing control or dying). Advise the 
patient, family, and designated support person of steps to take if relapse occurs.  
• Explain to the patient, family, and designated support person that the main goal 
is to provide a safe, secure place to receive treatment.  
• Explain how the behavioral health unit may be different than other settings. 
Interaction is promoted between patients and staff, and group meetings are 
encouraged. To ensure patients’ safety, they are checked on frequently 
throughout the day.  
• Educate the family and designated support person regarding the nature of 
psychiatric illness and expected signs and symptoms (e.g., pounding heartbeat, 
sweating, shortness of breath, chest pain, nausea, dizziness, feeling unreal or 
detached, fear of losing control or dying).  
• Assist the patient, family, and designated support person with engaging and 
participating as drivers of the plan of care.  
• Explain the importance of following the medication regimen as ordered. The 
patient should not alter the dose or stop taking the medication even if symptoms 
have subsided and he or she is feeling better.  
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ASSESSMENT 
1. Perform hand hygiene.  
2. Introduce yourself to the patient, family, and designated support person.  
3. Verify the correct patient using two identifiers.  
4. Assess the patient’s mental status and ability to understand information and 
participate in decisions. Include the patient as much as possible in all decisions.  
5. Assess the patient for suicidal or homicidal ideation or thoughts of self-harm. Use 
an organization-approved standardized tool for suicide assessment.12  
6. Evaluate the patient’s, family’s, and designated support person’s understanding of 
the patient’s illness.  
7. Assess and discuss the patient’s goal for treatment.  
8. Collaborate with the patient, family, and designated support person to develop a 
plan of care.  
9. Identify the patient’s psychiatric advance directives, if available.  
10. Determine the patient’s desire for the family or designated support person to be 
kept informed and involved in treatment.  
11. Determine the family’s or designated support person’s ability to support the 
patient during treatment.  
12. Consider the use of a standardized tool for screening and assessment to 
determine the patient’s condition and severity. Tools to consider include the Panic 
Disorder Screener (PADIS), Patient Health Questionnaire-Panic Disorder (PHQ-PD), 
Panic Disorder Severity Scale (PDSS), and the Panic Disorder Severity Scale Self-
Report (PDSS-SR).3 
13. When assessing for panic disorder, understand that a patient can experience 
panic attacks related to substance use; other anxiety disorders, such as social 
anxiety; or medical conditions, such as hyperthyroidism or cardiac conditions.2 
 
STRATEGIES 
1. Perform hand hygiene.  
2. Verify the correct patient using two identifiers.  
3. Assess the patient for suicidal or homicidal ideation or thoughts of self-harm. Use 
an organization-approved standardized tool for suicide assessment.12 If homicidal or 
suicidal ideation is present, implement appropriate precautions based on the 
patient's status. 
4. Explain the strategies to the patient, family, and designated support person and 
ensure that they agree to treatment.  
5. Maintain a calm, collaborative communication approach, avoiding the use of 
coercion.  
6. Create an environment of trust that allows the development of a therapeutic 
relationship.  
7. Orient the patient to the unit. Include discussion of unit routines, guidelines, 
patients’ rights and expectations, and schedules. Inform the patient that he or she 
will be checked on frequently throughout the stay.  
8. Create an environment that advocates for the patient’s needs using an 
interdisciplinary team. Engage the team in collaborative assessment and treatment 
planning with the patient.  
9. Engage the patient in treatment, including participation in therapeutic groups and 
individual sessions.  
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10. Administer psychiatric medications as ordered and monitor the patient’s response 
to the medications.  
11. Monitor the patient’s responses and social interactions in the milieu; reinforce 
appropriate social skills.  
12. Implement appropriate precautions based on the patient’s status.  
13. Respond to crisis in a calm, therapeutic, and nonthreatening manner. Use the 
least restrictive interventions to prevent harm to patients or staff.  
14. Collaborate with the patient, family, designated support person, and team in 
identifying the physical signs and symptoms the patient experiences at the time of a 
panic attack to increase his or her awareness that the basis of the attack is anxiety 
and not a significant medical issue. 
 
Rationale: The signs and symptoms of panic disorder involve primarily 
physical manifestations that lead patients to seek medical attention for 
their condition.13  
 
15. Explain to the patient, family, and designated support person that panic attacks 
can happen spontaneously without any apparent trigger and that the experience of 
the attack can increase the signs and symptoms of panic, impacting the patient’s 
distress. 
 
Rationale: Exploring the patient’s experiences during a panic attack 
and discussing common aspects of panic can be reassuring to the 
patient who feels he or she is losing control during an attack.9 
 
 
16. Collaborate with the patient, family, designated support person, and team in 
planning for patient discharge and follow-up care.  
17. Provide the appropriate education related to medications, crisis management, 
and follow-up care to the patient, family, and designated support person at the time 
of discharge.  
18. Explain to the patient, family, and designated support person that ongoing 
treatment is vital to continuing recovery. Making and keeping follow-up 
appointments is critical.  
19. Perform hand hygiene.  
20. Document the strategies in the patient’s record. 
 
REASSESSMENT 
1. Reassess the patient’s pain status and provide appropriate pain management 
(e.g., medication, relaxation, mindfulness skills). 
2. Reassess the patient’s experience of panic attacks. 
3. Reassess the patient’s signs and symptoms of agoraphobia. 




• The patient does not experience panic attacks. 
• The patient does not experience symptoms of agoraphobia. 
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• The patient, family, and designated support person have an understanding of the 
nature of panic disorder and agoraphobia. 
 
UNEXPECTED OUTCOMES 
• The patient experiences recurrence of panic attacks. 
• The patient refuses to participate in activities due to extreme discomfort about 
leaving his or her room. 
• The patient continues to experience symptoms of agoraphobia. 
• The patient, family, and designated support person do not have an understanding 




• Patient’s behaviors and response to interventions  
• Patient’s progress toward goals  
• Assessment of pain, treatment if necessary, and reassessment 
• Results of any standardized screening or assessment tools administered 
• Results of assessment of cardiac status 
 
ADOLESCENT CONSIDERATIONS 
• Agoraphobia and panic disorder do not generally manifest during early 
adolescence.8 
 
OLDER ADULT CONSIDERATIONS 
• Agoraphobia is one of the most prevalent anxiety disorders in older adults and 
may have its onset in late life.5 
 
SPECIAL CONSIDERATIONS 
• There is an association between panic disorder and mitral valve prolapse (MVP); 
therefore, patients with panic disorder should be evaluated for MVP.15  
• Pregnant patients with untreated panic disorder have a higher risk of 
experiencing birth complications, including premature birth, low-birth-weight 
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